Anchiano therapeutics ltd. (ANCN)
Income statement / Yearly
Dec'19Dec'18
Operating expenses:
Research and development

13,303

7,514

General and administrative

6,245

5,521

Restructuring expense

3,350

-

Total operating expenses

22,898

13,035

Finance (income) expense, net

4,226

457

LOSS BEFORE INCOME TAX

27,124

13,492

INCOME TAXES, NET

-

306

Net loss and comprehensive loss

-27,124

-13,798

Basic and diluted loss per share

0.79

1.09

Weighted average number of shares outstanding - basic and diluted

34,446

12,634

OTHER COMPREHENSIVE INCOME:
Foreign currency translation adjustments

-

-415

TOTAL COMPREHENSIVE LOSS

27,124

13,383